Order Article Reprints

Hunter E, Salter M, Powell R, Dring A, Naithani T, Chatziioannou ME, Gebregzabhar A, Issa M, Green J, Ng S, et al. Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications. Cancers. 2023; 15(10):2696. https://doi.org/10.3390/cancers15102696

Hunter, Ewan, Matthew Salter, Ryan Powell, Ann Dring, Tarun Naithani, Maria Eleni Chatziioannou, Abel Gebregzabhar, Mutaz Issa, Jayne Green, Serene Ng, and et al. 2023. "Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications" Cancers 15, no. 10: 2696. https://doi.org/10.3390/cancers15102696

Hunter, E., Salter, M., Powell, R., Dring, A., Naithani, T., Chatziioannou, M. E., Gebregzabhar, A., Issa, M., Green, J., Ng, S., Lim, C. R., Keat, C. S., Suan, A. T., Raman, R., Fatt, H. K., Luen, F. L. W., Alshaker, H., Pchejetski, D., Blum, D., ... Akoulitchev, A. (2023). Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications. Cancers, 15(10), 2696. https://doi.org/10.3390/cancers15102696